Key result
Multimodality imaging with echo and CMR remains essential for diagnosing, risk-stratifying, and monitoring cardiomyopathies.
Multimodality imaging, particularly echocardiography and CMR, is the cornerstone for diagnosing, risk stratifying, and monitoring patients with cardiomyopathies.
Answers are grounded in this paper and cite their sources.
Supports multimodality imaging in cardiomyopathies; leaves open standardization of protocols and outcome validation.
Cardiomyopathies are a group of structural and/or functional myocardial disorders which encompasses hypertrophic, dilated, arrhythmogenic, restrictive, and other cardiomyopathies. Multimodality cardiac imaging techniques are the cornerstone of cardiomyopathy diagnosis; transthoracic echocardiography should be the first-line imaging modality due to its availability, and diagnosis should be confirmed by cardiovascular magnetic resonance, which will provide more accurate morphologic and functional information, as well as extensive tissue characterization. Multimodality cardiac imaging techniques are also essential in assessing the prognosis of patients with cardiomyopathies; left ventricular ejection fraction and late gadolinium enhancement are two of the main variables used for risk stratification, and they are incorporated into clinical practice guidelines. Finally, periodic testing with cardiac imaging techniques should also be performed due to the evolving and progressive natural history of most cardiomyopathies.
No takes yet. Share an insight, caveat, or question.
Casas et al. (2022) conducted a review in Cardiomyopathies. Multimodality cardiac imaging was evaluated. Multimodality cardiac imaging techniques, including echocardiography and cardiovascular magnetic resonance, are essential for the diagnosis, risk stratification, and monitoring of cardiomyopathies.
Synapse has enriched 10 related papers. Consider them for comparative context: